Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kriya Hops is a dietary supplement developed by the Peak Health Foundation, featuring cannabidiol (CBD) extracted from a patented variety of Asian hops (Humulus yunnanensis). Unlike traditional CBD derived from cannabis or hemp, this product utilizes hops flowers that naturally contain CBD due to historical cross-pollination with wild cannabis in the Silk Road region of northern India. The extract is naturally THC-free and includes other non-psychotropic cannabinoids and terpenes such as cannabigerol (CBG), cannabichromene (CBC), beta-caryophyllene, and alpha-humulene. It is marketed for supporting the endocannabinoid system to promote immune health, mood stability, and relief from minor discomfort caused by everyday activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kriya Hops.